Dachaigh › Lymphoma
Sgrùdaidhean clionaigeach Lymphoma a’ fastadh anns na SA
Tha 142 sgrùdaidhean airson Lymphoma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX34 sgrùdaidhean
- Boston, MA33 sgrùdaidhean
- New York City, NY33 sgrùdaidhean
- Washington, DC23 sgrùdaidhean
- Baldwin Park, CA21 sgrùdaidhean
- Chicago, IL20 sgrùdaidhean
- Durham, NC17 sgrùdaidhean
- St. Louis, MO15 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Cleveland, OH14 sgrùdaidhean
- Edison, NJ12 sgrùdaidhean
- Atlanta, GA12 sgrùdaidhean
- Seattle, WA12 sgrùdaidhean
- Salt Lake City, UT11 sgrùdadh
- Rochester, MN11 sgrùdadh
- Nashville, TN11 sgrùdadh
- Columbus, OH11 sgrùdadh
- Miami, FL11 sgrùdadh
- Pittsburgh, PA10 sgrùdaidhean
- Los Angeles, CA10 sgrùdaidhean
- Dallas, TX10 sgrùdaidhean
- Queens, NY10 sgrùdaidhean
- Mountain View, CA9 sgrùdaidhean
- Denver, CO9 sgrùdaidhean
- Portland, OR9 sgrùdaidhean
- Greenburgh, NY9 sgrùdaidhean
- Milwaukee, WI9 sgrùdaidhean
- Aurora, CO8 sgrùdaidhean
- Birmingham, AL8 sgrùdaidhean
- East Norwalk, CT8 sgrùdaidhean
- Staten Island, NY8 sgrùdaidhean
- Cincinnati, OH8 sgrùdaidhean
- San Antonio, TX7 sgrùdaidhean
- Tampa, FL7 sgrùdaidhean
- New Haven, CT7 sgrùdaidhean
- New Rochelle, NY7 sgrùdaidhean
- Omaha, NE7 sgrùdaidhean
- Phoenix, AZ7 sgrùdaidhean
- Kansas City, MO6 sgrùdaidhean
- Buffalo, NY6 sgrùdaidhean
Le stàit
- Alabama9 sgrùdaidhean
- Arizona11 sgrùdadh
- Arkansas3 sgrùdaidhean
- California40 sgrùdaidhean
- Colorado16 sgrùdaidhean
- Connecticut7 sgrùdaidhean
- Florida25 sgrùdaidhean
- Georgia16 sgrùdaidhean
- Illinois23 sgrùdaidhean
- Indiana6 sgrùdaidhean
- Iowa6 sgrùdaidhean
- Kansas7 sgrùdaidhean
- Kentucky5 sgrùdaidhean
- Maryland21 sgrùdaidhean
- Massachusetts33 sgrùdaidhean
- Michigan12 sgrùdaidhean
- Minnesota14 sgrùdaidhean
- Missouri17 sgrùdaidhean
- Nebraska7 sgrùdaidhean
- New Jersey18 sgrùdaidhean
- New York42 sgrùdaidhean
- North Carolina22 sgrùdaidhean
- Ohio29 sgrùdaidhean
- Oklahoma4 sgrùdaidhean
- Oregon9 sgrùdaidhean
- Pennsylvania24 sgrùdaidhean
- Sgìre Cholumbia7 sgrùdaidhean
- South Carolina4 sgrùdaidhean
- Tennessee15 sgrùdaidhean
- Texas45 sgrùdaidhean
- Utah14 sgrùdaidhean
- Virginia10 sgrùdaidhean
- Washington12 sgrùdaidhean
- Wisconsin12 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02917083Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT03258567Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
A’ fastadhSgrùdadh amharc
Aoisean 3 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01441089Rutgers University Study of the Genetics of Blood Cancers
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07714044T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06343311Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05442515A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07015242A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
A’ fastadhÌre 2
1 Month – 17 Years · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT04570423Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07583810Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00006518A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07013435Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07014293Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03418038Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00923507Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03223610A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
A’ fastadhÌre 1/2
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04094610Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
A’ fastadhÌre 1
24 Months – 18 Years · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06441331Epco, Zanu, Ritux for R/R FL or MZL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06563596Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06398457Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT02974647CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04083495Precise Oncology Interventions in Nutrition and Training (OnPoint)
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06534918Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT04301076Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.